Neochem Bio

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE21UM01018
  • NSEID: NEOCHEM
  • BSEID:
INR
98.00
0.00 (0.00%)
BSENSE

Jun 10, 03:30 PM

BSE+NSE Vol: 16800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 31.52%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 61.69%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 55.08%

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 0.00%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Neochem Bio With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
110.70
73.47
37.23
50.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
110.70
73.47
37.23
50.67%
Raw Material Cost
73.57
48.53
25.04
51.60%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.17
2.36
-1.19
-50.42%
Employee Cost
8.17
8.21
-0.04
-0.49%
Power Cost
0.00
6.12
-6.12
-100.00%
Manufacturing Expenses
0.01
0.01
0.00
Selling and Distribution Expenses
1.62
0.00
1.62
Other Expenses
6.31
4.50
1.81
40.22%
Total Expenditure (Excl Depreciation)
90.85
69.73
21.12
30.29%
Operating Profit (PBDIT) excl Other Income
19.85
3.74
16.11
430.75%
Other Income
2.70
3.17
-0.47
-14.83%
Operating Profit (PBDIT)
22.55
6.91
15.64
226.34%
Interest
3.51
7.02
-3.51
-50.00%
Exceptional Items
-0.62
0.00
-0.62
Gross Profit (PBDT)
18.42
-0.11
18.53
16,845.45%
Depreciation
1.24
4.85
-3.61
-74.43%
Profit Before Tax
17.18
-4.96
22.14
446.37%
Tax
5.16
2.15
3.01
140.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.03
-7.11
19.14
269.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.03
-7.11
19.14
269.20%
Equity Capital
17.12
27.30
-10.18
-37.29%
Face Value
10.00
10.00
0.00
Reserves
61.72
113.62
-51.90
-45.68%
Earnings per share (EPS)
7.03
-2.60
9.63
370.38%
Diluted Earnings per share
8.71
-3.00
11.71
390.33%
Operating Profit Margin (Excl OI)
17.93%
5.09%
0.00
12.84%
Gross Profit Margin
16.64%
-0.15%
0.00
16.79%
PAT Margin
10.87%
-9.68%
0.00
20.55%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 110.70 Cr
in Mar 2026

Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 12.03 Cr
in Mar 2026

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.85 Cr
in Mar 2026

Figures in Cr
Annual - Interest
Interest 3.51 Cr
in Mar 2026

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.93%
in Mar 2026

Figures in %